Our website will be undergoing planned maintenance starting at 5:00 PM EST on Dec. 11 and will be back in the morning of Dec. 12. During this time some features will be unavailable, like login and signup.
Our website will be undergoing planned maintenance starting at 5:00 PM EST on Dec. 11 and will be back in the morning of Dec. 12. During this time some features will be unavailable, like login and signup.

 CLSI Publishes New Microbiology Standard and Supplement

12/4/2018

Wayne, Pennsylvania,Clinical and Laboratory Standards Institute has published M24--Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes, 3rd Edition and M62--Performance Standards for Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes, 1st Edition. 

M24 includes susceptibility testing procedures for Mycobacterium tuberculosis complex (MTBC), clinically significant slowly and rapidly growing mycobacterial species, Nocardia spp., and other aerobic actinomycetes. Also included in this standard are recommendations for selecting agents for first-line and second-line drug testing, organism group-specific methodologies, reporting recommendations, and organism quality control criteria. Recommendation regarding agent selection for testing mycobacteria are based primarily on published guidelines.

Clinical and Laboratory Standards Institute document M62—Performance Standards for Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes includes the minimal inhibitory concentrations and quality control ranges developed following the standards described in CLSI document M24.1 The data in the tables are valid only when the methodology in CLSI document M241 is followed. 

For moreinformation about M24 and M62, contact Patrick McGinn atpmcginn@clsi.orgor +1.484.588.5933. 

 

CLSI sets the standard for quality in medical laboratory testing. A not-for-profit membership organization, CLSI brings together the global laboratory community for the advancement of a common cause: to foster excellence in laboratory medicine. 

For nearly 50 years, our members, volunteers, and customers have made CLSI a respected, transformative leader in the development and implementation of medical laboratory testing standards. Through our unified efforts, we will continue to set and uphold the standards that drive quality test results, enhance patient care delivery, and improve health care around the world. 

By using CLSI standards, laboratorians can improve process quality, speed the development of standard operating procedures, and implement safer practices with greater ease and efficiency.

 

← Go Back